Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Morlock

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Postgraduate Medicine|November 24, 2015
Management of gout in the real world: current practice versus guideline recommendationsPaul P Doghramji, Steve Fermer, Robert Wood, et al.
International Journal of Methods in Psychiatric Research|August 19, 2010
Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorderLouis S Matza, Robert Morlock, Chris Sexton, et al.
Psychiatry Research|August 12, 2009
Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophreniaDawn I Velligan, Larry Alphs, Scott Lancaster, et al.
Journal of Medical Economics|June 20, 2013
Corroboration of claims algorithm for second-line costs of metastatic colorectal cancer treatment with targeted agentsStacey Dacosta Byfield, Elaine Yu, Robert Morlock, et al.
Frontiers in Psychiatry|May 6, 2026
Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021Sofia Abramsky-Sze, Elliot Marseille, Richard Matzopoulos, et al.
Journal of Managed Care & Specialty Pharmacy|May 23, 2017
Cardiovascular Disease and Gout: Real-World Experience Evaluating Patient Characteristics, Treatment Patterns, and Health Care UtilizationMichael H Pillinger, Sripal Bangalore, Alyssa B Klein, et al.
International Journal of Methods in Psychiatric Research|May 4, 2011
Validation of a 4-item Negative Symptom Assessment (NSA-4): a short, practical clinical tool for the assessment of negative symptoms in schizophreniaLarry Alphs, Robert Morlock, Cheryl Coon, et al.
Journal of Medical Economics|October 6, 2018
The economic burden of uncontrolled gout: how controlling gout reduces costNatalia M Flores, Javier Nuevo, Alyssa B Klein, et al.
The Patient|December 7, 2018
Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer: Qualitative Findings from Patient and Physician InterviewsStefan Holmstrom, Shevani Naidoo, James Turnbull, et al.
Ejhaem|June 19, 2024
Development of the treatment preference in myelodysplasia questionnaire for clinicians, carers, and patientsRobert Morlock, Chun Fong, Francesco Castaldi, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Postgraduate Medicine|November 24, 2015
Management of gout in the real world: current practice versus guideline recommendationsPaul P Doghramji, Steve Fermer, Robert Wood, et al.
International Journal of Methods in Psychiatric Research|August 19, 2010
Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorderLouis S Matza, Robert Morlock, Chris Sexton, et al.
Psychiatry Research|August 12, 2009
Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophreniaDawn I Velligan, Larry Alphs, Scott Lancaster, et al.
Journal of Medical Economics|June 20, 2013
Corroboration of claims algorithm for second-line costs of metastatic colorectal cancer treatment with targeted agentsStacey Dacosta Byfield, Elaine Yu, Robert Morlock, et al.
Frontiers in Psychiatry|May 6, 2026
Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021Sofia Abramsky-Sze, Elliot Marseille, Richard Matzopoulos, et al.
Journal of Managed Care & Specialty Pharmacy|May 23, 2017
Cardiovascular Disease and Gout: Real-World Experience Evaluating Patient Characteristics, Treatment Patterns, and Health Care UtilizationMichael H Pillinger, Sripal Bangalore, Alyssa B Klein, et al.
International Journal of Methods in Psychiatric Research|May 4, 2011
Validation of a 4-item Negative Symptom Assessment (NSA-4): a short, practical clinical tool for the assessment of negative symptoms in schizophreniaLarry Alphs, Robert Morlock, Cheryl Coon, et al.
Journal of Medical Economics|October 6, 2018
The economic burden of uncontrolled gout: how controlling gout reduces costNatalia M Flores, Javier Nuevo, Alyssa B Klein, et al.
The Patient|December 7, 2018
Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer: Qualitative Findings from Patient and Physician InterviewsStefan Holmstrom, Shevani Naidoo, James Turnbull, et al.
Ejhaem|June 19, 2024
Development of the treatment preference in myelodysplasia questionnaire for clinicians, carers, and patientsRobert Morlock, Chun Fong, Francesco Castaldi, et al.
Pageof 5